The Stock
Wellness Check
Have you invested in the right stocks for your clients? Does your portfolio consistently beat the benchmark?
A stock analysis that relies on traditional methods like linear regression fails to capture intrinsic relationships among complex datasets such as sentiment, alternative, pricing and fundamental information.
K Score, a stock rating score of 1 to 9, is developed using machine learning models and algorithms that process vast and diverse datasets to mine alpha that cannot be rivaled by statistical analysis. The higher the rating (7-9), the greater probability of out-performance in the near future. The lower the rating (1-3), the weaker the stock.
A portfolio constructed using K Scores of 9 (Top Picks Portfolio) has out-performed the S&P 500.
You too, can participate in this!
For a limited time, we are offering a FREE Stock Wellness Check ($500 value) that uses our award-winning K Score.
Our AI driven models use predictive analytics for future out-performance.
We assimilate complex data, including fundamental, technical and alternative.
Our methodology is grounded in factor investing and rigorous quantitative analysis.
This is a onetime snapshot of the health of yours or your clients’ stocks. Use the Stock Wellness Check to validate your investment, and research buy/sell signals to optimize your portfolio.
A Sample Stock Wellness Check Result
| Company Name | Symbol | Sector | K Score |
|---|---|---|---|
| O’Reilly Automotive,Inc. | ORLY | Consumer Discretionary | 9 |
| 3M Company | MMM | Industrials | 7 |
| Hershey Company | HSY | Consumer Staples | 7 |
| JMP Group LLC | JMP | Financials | 3 |
*On mobile devices, please swipe to the right to see sample data.
How Do I Sign Up?
Click below and we will email you with instructions. Within one business week, we will send your clients’ Stock Wellness Check.
You will receive:
- A one-time Stock Wellness Check
- The ability to see up to 100 stocks
- A report on your stock holdings rated by our award-winning K Score
LEGAL DISCLAIMER
Kavout is not an investment advisory firm. The data products and services are considered investment tools, and for informational purposes only. It does not constitute a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory or other services.
